Trial Profile
Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Jun 2023
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Glucagon like peptide 1 receptor agonists
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 12 Jun 2023 Planned End Date changed from 1 Dec 2035 to 1 Dec 2039.
- 12 Jun 2023 Planned primary completion date changed from 1 Dec 2035 to 1 Dec 2039.
- 26 Feb 2018 Planned End Date changed from 1 Dec 2027 to 1 Dec 2035.